The NCI Developmental Therapeutics Program and Cancer Imaging Program provides a Drug Development Consultation Service to investigators from academia or small biotech companies looking for assistance with preclinical development of small molecule, biological, or imaging drugs for cancer.
The service typically consists of a one-hour call that could assist you with:
- Discovery strategy
- Design of nonclinical safety studies
- Manufacturing plan
- Investigational new drug plan
- Communication with the Food and Drug Administration
- Superior application for supplemental drug development services to the NCI Experimental Therapeutics (NExT) Program (request a consultation with NExT).